Rosalind Franklin University Incubator Company Announces Positive Anti-Fibrotic Effects in Lung Disease Model
BLR Bio, a biotechnology company in Rosalind Franklin University’s Helix 51 incubator, announced…
News Archive
“We Need to Intervene”: Casting a Spotlight on Vehicular Crashes
Every day across the United States, too many drivers find themselves involved in motor vehicle accidents (MVAs). A startling…
FDA Awards Orphan Drug Designation for Brain Cancer Drug Development by Helix 51 Company
U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has…
Dr. Erin Howe Awarded Research Grant to Study Molecular Mechanisms Driving Metastatic Breast Cancer
Rosalind Franklin University cancer biologist Erin Howe, PhD, has been awarded a $100,000 grant…
NIH Fast-Track Grant for Novel Therapeutic to Treat Glioblastoma Awarded to Rosalind Franklin University Helix 51 Incubator Company
U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has…
NIH Awards $9.8 million in Funding to Rosalind Franklin University Researchers for Projects Related to Brain Function and Diseases, Cancer and Parasitic Infections
Three Rosalind Franklin University scientists have been awarded approximately $9.8 million in funding…
New Directions: Center for Genetic Diseases
The new director of the Center for Genetic Diseases, molecular biologist Weihang “Valerie” Chai, PhD, wants to establish…
Grainger Support Primes Startups for Success
From nurturing companies in a world-class research environment to providing hands-on experiences for students, the Helix…
ASRC 2024 Spotlights Student, Postdoc Research
Research excellence was on full display during RFU’s 19th annual All School Research Consortium and accompanying Art…
Improving the Health and Performance of Women Warfighters
The correlation between the brain and body is an intricate, precise system that is overlooked by most of us in day-to-day…